Back to top

Image: Bigstock

BioCryst Pharmaceuticals (BCRX) Shares March Higher, Can It Continue?

Read MoreHide Full Article

BioCryst Pharmaceuticals, Inc. (BCRX - Free Report) has been on the move lately as the stock has risen by 46.8% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but the question that has to be on investors’ minds right now is; can this trend continue?

While there can be no telling for sure, it is certainly encouraging that earnings estimates have risen in the past few weeks on the company, suggesting that sentiment on BCRX is moving in the right direction. In fact, the stock currently has a Zacks Rank #2 (Buy), suggesting that the recent run could certainly continue for this in-focus company. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.  

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think. See This Ticker Free >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


BioCryst Pharmaceuticals, Inc. (BCRX) - free report >>